Risk of Recurrence After Anti-Seizure Medication Discontinuation

With appropriate anti-seizure medication, long-term seizure freedom can be achieved in about 2/3 of patients with epilepsy. After long-term seizure freedom, the idea of medication discontinuation arises for both patients and physicians. In this study, we aimed to investigate seizure recurrence rates and the factors affecting recurrence in patients whose anti-seizure medication treatment was discontinued. Fifty patients were included in the study. Twenty-eight (56%) patients were female, with a mean age of 41.28±14.58 years and a mean duration of epilepsy of 15.20±9.90 years. Recurrence was observed in 14 (28%) patients. When the recurrence risk factors were analyzed, it was observed that the risk of recurrence decreased as the seizure-free period increased. Our study supports that the risk of relapse after discontinuation of anti-seizure medications decreases as the seizure-free period is prolonged. However, it should not be forgotten that the decision to discontinue medication should be individualized.

Authors

Institutions

Publication Details

Journal
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
Published
2024-08-23
DOI
https://doi.org/10.47572/muskutd.1482913
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of Recurrence After Anti-Seizure Medication Discontinuation

Firdevs Ezgi Uçan Tokuç, Fatma Genç, Yasemin Bıçer Gömceli, Abidin Erdal et al.
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
Epilepsy research and treatment
article

Risk of Recurrence After Anti-Seizure Medication Discontinuation

Firdevs Ezgi Uçan Tokuç, Fatma Genç, Yasemin Bıçer Gömceli, Abidin Erdal, Meltem Korucuk, Merve Gürsoy Hasoğlan
article en

Abstract

With appropriate anti-seizure medication, long-term seizure freedom can be achieved in about 2/3 of patients with epilepsy. After long-term seizure freedom, the idea of medication discontinuation arises for both patients and physicians. In this study, we aimed to investigate seizure recurrence rates and the factors affecting recurrence in patients whose anti-seizure medication treatment was discontinued. Fifty patients were included in the study. Twenty-eight (56%) patients were female, with a mean age of 41.28±14.58 years and a mean duration of epilepsy of 15.20±9.90 years. Recurrence was observed in 14 (28%) patients. When the recurrence risk factors were analyzed, it was observed that the risk of recurrence decreased as the seizure-free period increased. Our study supports that the risk of relapse after discontinuation of anti-seizure medications decreases as the seizure-free period is prolonged. However, it should not be forgotten that the decision to discontinue medication should be individualized.

Muğla Sıtkı Koçman Üniversitesi Tıp DergisiVol. 11(2)
Ministry of Health (TR), Antalya Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR), Antalya IVF (TR), Ankara Bilkent City Hospital (TR)
Peace, Justice and strong institutions
Openalex Percentile: Top 81%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Risk of Recurrence After Anti-Seizure Medication Discontinuation — Firdevs Ezgi Uçan Tokuç, Fatma Genç, et al. · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi (2024) | TGRS Research Map | TGRS